ATE345791T1 - Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs - Google Patents

Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs

Info

Publication number
ATE345791T1
ATE345791T1 AT03701674T AT03701674T ATE345791T1 AT E345791 T1 ATE345791 T1 AT E345791T1 AT 03701674 T AT03701674 T AT 03701674T AT 03701674 T AT03701674 T AT 03701674T AT E345791 T1 ATE345791 T1 AT E345791T1
Authority
AT
Austria
Prior art keywords
lung cancer
dithiolethone
anethol
prevent lung
dysplastic lesions
Prior art date
Application number
AT03701674T
Other languages
English (en)
Inventor
Stephen Lam
Calum Macaulay
Riche Jean Le
Yulia Dyachkova
Andy Coldman
Martial Guillaud
Ernest Hawk
Marie-Odile Christen
Adi Gazdar
Original Assignee
Solvay Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharma filed Critical Solvay Pharma
Application granted granted Critical
Publication of ATE345791T1 publication Critical patent/ATE345791T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT03701674T 2002-02-13 2003-02-13 Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs ATE345791T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35582602P 2002-02-13 2002-02-13

Publications (1)

Publication Number Publication Date
ATE345791T1 true ATE345791T1 (de) 2006-12-15

Family

ID=27734564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701674T ATE345791T1 (de) 2002-02-13 2003-02-13 Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs

Country Status (8)

Country Link
US (1) US20050182128A1 (de)
EP (1) EP1474131B1 (de)
JP (1) JP2005522446A (de)
AT (1) ATE345791T1 (de)
AU (1) AU2003202763A1 (de)
CA (1) CA2475545A1 (de)
DE (1) DE60309834D1 (de)
WO (1) WO2003068219A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429190B (zh) * 2007-08-24 2013-03-27 沈阳药科大学 4,5-二取代苯基-3h-1,2-二硫杂环戊烯-3-硫酮、-酮、-酮肟类衍生物及其用途
CN101463030B (zh) * 2009-01-09 2012-03-21 福建深纳生物工程有限公司 茴三硫的制备方法
RU2534525C9 (ru) * 2013-09-24 2015-02-10 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Гликозидные производные 1,2-дитиол-3-тиона или 1,2-дитиол-3-она и лекарственные средства на их основе
BR112018004518A2 (pt) 2015-09-08 2019-03-19 OP2 Drugs compostos para o tratamento de doenças ligadas à produção de espécies reativas de oxigênio (ros) mitocondriais
WO2017042267A1 (en) * 2015-09-08 2017-03-16 Orphan Partners 2 Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ros) production
AU2017323504A1 (en) 2016-09-12 2019-05-02 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
KR20190089851A (ko) 2016-09-12 2019-07-31 에스티 아이피 홀딩 아게 4-메틸-5-(피라진-2-일)-3h-1,2-디티올-3-티온의 제제, 맛-개질 제제, 및 그의 제조 및 사용 방법
CA3055122A1 (en) 2017-03-07 2018-09-13 OP2 Drugs Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ros) production
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Also Published As

Publication number Publication date
AU2003202763A1 (en) 2003-09-04
CA2475545A1 (en) 2003-08-21
EP1474131A1 (de) 2004-11-10
JP2005522446A (ja) 2005-07-28
EP1474131B1 (de) 2006-11-22
WO2003068219A1 (en) 2003-08-21
US20050182128A1 (en) 2005-08-18
DE60309834D1 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
ATE497770T1 (de) Pharmazeutische formulierungen von decitabin
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
ATE268179T1 (de) Verwendung von substituierten imidazo (1,2- a)pyridin-, -pyrimidin- und -pyrazin-3-yl-amin- derivaten zur herstellung von medikamenten zur nos-inhibierung
BRPI0416628A (pt) uso de compostos orgánicos
WO2003080582A3 (de) Fredericamycin-derivate
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
EA200101046A1 (ru) Производные индигоидных бис-индолов
ATE410998T1 (de) Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut
GEP20094826B (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
SE0401342D0 (sv) Therapeutic compounds
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
ATE345791T1 (de) Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
SE9904421D0 (sv) New compounds
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
DE60115054D1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
ATE339202T1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
ATE444754T1 (de) Verwendung von tyrosinkinase-inhibitoren zur behandlung inflammatorischer prozesse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties